查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1521102

生物医用纺织品市场－2024年至2029年预测

Biomedical Textiles Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预测2024-2029年期间，全球生物医学纺织品市场将以6.5%的复合年增长率成长。

全球生物医用纺织品市场受到心血管、整形外科、脊椎和其他疾病发生率上升等几个核心因素的推动。根据联合国预测，全球65岁及以上人口预计将从2022年的10%增加到2050年的16%。到 2050 年，老年人口数量将超过五岁以下儿童。这给了很大一部分人口与整形外科、心血管等相关的严重健康问题，并增加了对生物医学纺织品等创新保健产品的需求。生物医学纺织品市场领域高度以研究为导向，为学术实验室和健康新兴企业提供合作开发新产品的机会。

  • 人们正在寻求多学科和跨学科的方法，包括纺织贴片、相容的聚合物医疗植入和增强型个人防护装备。进一步的研究和应用领域包括静电纺奈米纤维、3D 列印、聚合物和抗菌涂层。
  • 该领域在整个纺织及相关行业的研发、产品开发以及与监管机构的合作方面拥有研究机会。此栏位有多个领域，可根据您的可自订需求进行应用。

生物医用纺织品市场驱动因素

  • 心血管疾病增加

由于生活方式的改变，心血管疾病在全世界不断增加。吸烟、不健康饮食、久坐的生活方式、缺乏运动和过量摄取等行为风险因素也会增加风险因素。这会增加血压、血糖、血脂和超重。这些因素会增加心血管疾病的风险。在美国，心血管疾病是男性、女性以及大多数种族和民族的人的第一大死因。根据疾病管制美国的数据，每 33 秒就有一人死于心血管疾病。

这些数字表明心臟病正在增加。人们越来越关注心臟健康和整体生活方式问题。由于心臟病的增加，心血管手术的数量也在增加。创新解决方案的应用带来了无限的效能可能性。

此前，生物医学纺织品仅限于传统的主动脉瓣修復移植物和心臟瓣膜缝合袖口。然而，心臟瓣膜织物解决方案现在用于多种应用。生物医学纺织品的复杂应用可用于受损心血管组织的癒合和再生。我们可以生产主动脉弓加固、覆膜支架、颈动脉修復织物、生物相容性心臟瓣膜织物等。

Confluence Medical Technologies 开发和製造用于各种应用（包括心血管）的植入式纺织品。该公司生产用于主动脉瓣和二尖瓣的经导管瓣膜裙部、用于心耳阻塞设备的敷料以及血管内血管支架。该公司还生产仪器框架上的无缝编织配件，无需缝纫或手工组装。

  • 扩大整形外科应用

骨科生物技术的进步提供了具有所需机械和生物效益的合成生物材料。这可应用于骨移植和融合、脊椎运动的维持、组织固定以及软骨、肌腱、韧带和半月软骨的修復。在整形外科，患者的年龄层正在转变为年轻患者。

这些人体力活动较多，容易造成软组织损伤，包括韧带和肌腱损伤。所有这些伤害都与运动、健身房、健行、骑自行车和其他冒险活动有关。身体活动相关的伤害在这一人群中变得非常普遍，导致需要进行手术。趋势是避免大手术、早期疗育和微创设备。

纺织品在整形外科的主要优势在于其微创性、形状变形、高拉伸强度、结构稳定性、生物相容性、柔韧性、多孔性、能够透过小孔进入并在体内扩张等关键特性。一些生物医学结构的几何形状可以客製化以影响孔隙率和组织整合，或作为组织屏障。这些结构具有固有的可压缩和可形状变形的特性，使其适用。应用包括运动缝合线和组件、关节和韧带固定和重组装置以及脊椎融合繫绳。

生物医用纺织品 - 地理视角

  • 在预测期内，亚太地区将主导生物医用纺织品市场。

中国、日本、印度、韩国等主要经济体在亚太地区占据主导地位。这一地区也包括东南亚国协等快速发展的新兴国家。印度医疗保健产业持续强劲成长和扩张，私营和政府部门的产值均达到 3,720 亿美元。

该行业是该国最大的雇主，截至 2024 年僱用了 750 万人。印度医疗保健公共支出占 GDP 的比重从 2021 财年的 1.6% 增加到 2.1%（2023 财年）和 2.2%（2022 财年）。 2024年医疗旅游市场规模预估为76.9亿美元。这些不断增加的数字清楚地表明医疗设备应用范围不断扩大和创新产品的开发。

此外，中国是全球第二大医疗保健市场，医疗设备是重要的医疗保健销售力量。根据国际贸易管理局官网数据显示，中国医疗设备市场预计将以8.3%的复合年增长率扩张，到2026年将达到488亿美元。由于生物医学纺织品用于心血管、整形外科和组织工程等多种用途，对生物医学纺织品的需求可能会增加。

生物医用纺织品市场的限制因素：

  • 生物医用纺织品难以采购和製造，因此专门从事该领域的公司具有优势。製造和设计的复杂性对于该领域的老字型大小企业来说可能是一个优势。
  • 这对于必须进行价格竞争的新公司来说是一个挑战。由于需要高水准的研发，市场的快速成长受到限制。

生物医用纺织品市场的主要发展：

  • 2024 年 1 月，Cortland Biomedical 增加了两台提花织机，扩大了其织造能力。这将增强我们设计和开发织造医学纺织品结构的能力和能力。这项策略倡议为医用纺织品的进步开闢了新途径。 Cortland Biomedical 保证与线张紧繫统的完美连接。平纹和窄纹织物，包括梭织和剑桿织造，可用于创建用于血管移植等应用的三维结构。 Cortland Biomedical 利用多年的医用纺织工程（包括针织、编织和机织）经验来设计、客製化和製造高性能生物医用纺织结构。
  • 2023 年 3 月，Riverpoint 宣布将透过帝斯曼生物医学的独家许可扩大其生物产品供应。 Riverpoint Medical 目前持有帝斯曼生物医学独家授权的专有骨传导 (OC) 涂层技术。骨传导是指骨头在表面生长并随着时间的推移被新骨头取代。该公司创造了一种可以改善促进骨附着的环境的产品。骨传导涂层用于整形外科和牙科植入，现在也用于可植入纺织产品。这是整形外科的突破，其中骨传导支架是修復的重点。 Riverpoint Medical 和 DSM Biomedical 专有的 OC 涂层技术改善了外科医生和患者的植入式纺织品。
  • 2022 年 10 月，Cortland Biomedical 推出了一种包含渗透性线纤维的纺织结构。该公司目前能够加工渗透性纤维。在诊断应用中使用渗透性纤维可以使仪器在萤光镜下可视化，并具有适合其预期用途的机械性能。这允许外科医生定位器械。手术放置后数月甚至数年可透过萤光镜检查来确认可见度。该公司广泛的针织、机织和编织能力使其能够创造具有特定机械性能的复杂和客製化的纺织结构。目前，渗透性纤维有 PET 和 UHMWPE 两种材质。

生物医用纺织品市场细分与分析如下：

依纤维类型

  • 非生物分解纤维
  • 生物分解性纤维

按布料类型

  • 编织
  • 织物
  • 不织布
  • 其他的

按用途

  • 心血管
  • 血管内的
  • 整形外科
  • 神经血管的
  • 缝合
  • 其他的

按地区

  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
    • 心血管疾病增加
    • 扩大整形外科应用
    • 人口老化加剧
  • 市场限制因素
    • 设计和製造复杂性
  • 波特五力分析
  • 产业价值链分析

第五章生物医用纺织品市场：依纤维类型

  • 介绍
  • 非生物分解纤维
  • 生物分解性纤维

第六章生物医用纺织品市场：依布料类型

  • 介绍
  • 编织
  • 织物
  • 不织布材料
  • 其他的

第七章生物医用纺织品市场：依应用分类

  • 介绍
  • 心血管
  • 血管内的
  • 整形外科
  • 神经血管的
  • 缝合
  • 其他的

第八章生物医用纺织品市场：按地区

  • 世界概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东/非洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Poly-Med Incorporated
  • Medical Murray
  • Bally Ribbon Mills
  • Swicofil AG
  • Royal DSM
  • Confluent Medical Technologies
  • 3M
  • Atex Technologies
  • Aran Biomedical Teoranta
  • Freudenberg Group
  • Trelleborg
  • Asahi Kasei Corporation
  • Elkem Silicones
  • Cortland Biomedical
简介目录
Product Code: KSI061616917

The global biomedical textiles market will grow at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2024 to 2029.

The global biomedical textiles market is driven by several core factors, including increasing cardiovascular diseases, orthopedics, spinal, and other disorders. According to the United Nations, the global population aged 65 and above is expected to rise from 10% in 2022 to 16% in 2050. The older population will surpass the number of children under age 5 by 2050. This is creating serious health-related issues for a large section of the population related to orthopedics, cardiovascular, etc., and causing the need for innovative health products like biomedical textiles. The biomedical textiles market sector is highly research-based and provides opportunities for academic research laboratories and health startups to collaborate and develop new products.

  • There has been a push for inter- and trans-disciplinary approaches, in using textiles for patches, compatible polymer-based medical implants, and PPE with enhanced functionalities. Further domains for research and application are electrospun nanofibers, 3D printing, polymers, antibacterial coatings, etc.
  • The sector has opportunities for research through the industries for textiles and allied fields in R&D, product development, and working with regulatory bodies. This sector has multiple domains for application according to customizable needs.

BIOMEDICAL TEXTILES MARKET DRIVERS:

  • Growing cases of cardiovascular diseases-

Cardiovascular diseases are rising worldwide owing to the changing lifestyles. Behavioral risk factors such as tobacco use, unhealthy diet, sedentary lifestyle, physical inactivity, and overuse of alcohol are giving thrust to the risk factors. This causes raised blood pressure, blood glucose, blood lipids, and overweight. The risk of cardiovascular diseases has been increasing due to these factors. In the United States, cardiovascular diseases are the leading cause of death for men, women, and people of most racial and ethnic groups. According to the Centers for Disease Control, one person dies every 33 seconds from cardiovascular disease.

These figures indicate the increasing cases of heart diagnoses. People are becoming concerned about their heart health and overall lifestyle challenges. The growing number of heart diseases is causing an increasing number of heart surgeries. Innovative solutions have been applied to the limitless performance possibilities.

Earlier, biomedical textiles were limited to vascular grafts and heart valve sewing cuffs for traditional aortic valve repair. But now, heart valve fabric solutions are used in multiple applications. The complex application of biomedical textiles can be used for the healing and regeneration of damaged cardiovascular tissue. It can generate aortic arch reinforcement, stent graft covering, carotid artery repair fabric, and biocompatible heart valve fabric, among others.

Confluent medical technologies are developing and manufacturing implantable textiles for various applications, including cardiovascular. The company makes aortic and mitral transcatheter valve skirts, atrial appendage occlusion device coverts, or endovascular stent grafts. It also produces sutureless attachments of textiles to a device frame which eliminates the need for sewing and manual assemblies.

  • Growing application in orthopedics-

The advancement in orthobiologics provides synthetic biomaterials for the required mechanical and biological benefits. This can be applied for bone grafting and fusion, motion preservation in the spine, tissue fixation, cartilage, tendon, ligament, and meniscal repair. In the orthopedic, there has been a shift in the age demographics toward more younger patients.

These people are more physically active, causing soft-tissue injuries, including damage to the ligaments and tendons. All these injuries are associated with sports, gym, adventure like trekking, cycling, etc. Physical activity-related injuries are becoming very common among these populations, thus leading to surgeries. The trend is moving towards avoiding large-scale surgeries, earlier intervention, and less invasive devices.

Key benefits of textiles in orthopedics can be attributed to key features like less invasiveness, shape transformation, high tensile strength, stable structure, biocompatibility, flexibility, porosity, and features like entering through a small hole and then expanding in the body, among others. The geometry of several biomedical structures can be customized to affect porosity and tissue integration or act as a tissue barrier. These structures have applications due to their inherently compressible and shape-transformable properties. The application can be in sports med sutures and assemblies, joint and ligament fixation and reconstruction devices, and spinal fixation tethers.

BIOMEDICAL TEXTILES MARKET - GEOGRAPHICAL OUTLOOK

  • Asia Pacific region to dominate the biomedical textiles market during the forecast period.

The major economies like China, Japan, India, and South Korea dominate the Asia-Pacific region. Some of the fastest-growing emerging economies are from this region, such as ASEAN countries. The Indian Healthcare industry continued to show robust growth and expansion, reaching a value of US$372 billion both in the private sector and the government.

This sector has been the largest employer in the country, with 7.5 million as of 2024. India's public expenditure on healthcare touched 2.1 % of GDP in FY23 and 2.2% in FY22, a rise from 1.6% in FY21. The country's medical tourism market is valued at US$7.69 billion in 2024. These increased numbers significantly indicate the growing application of medical devices and development of the innovative products.

Additionally, China is the world's second-largest healthcare market, making medical devices an important healthcare sales. According to the Official Website of the International Trade Administration, the medical device market in China is expected to expand at a Compound Annual Growth Rate (CAGR) of 8.3%, making it US$48.8 billion by 2026. The biomedical textiles being used in the multipurpose applications of cardiovascular, orthopedic, and tissue engineering would likely rise in demand.

Biomedical Textiles Market Restraints:

  • Biomedical textiles are difficult to source and manufacture, this keeps the companies that are specialized in this segment better situated. The complexity of manufacturing and designing could be an added advantage for the well-established companies in this segment.
  • This is a challenge for new companies, which must compete on price. The high research and development required is limiting the fast market growth.

Biomedical textiles market Key Developments:

  • In January 2024, Cortland Biomedical expanded its weaving capabilities by incorporating two additional jacquard looms. It enhances the capabilities and capacity to design and develop woven biomedical textile structures. This strategic move will give new avenues for advancements in medical textiles. Cortland Biomedical ensures excellence in contact surfaces to yarn tensioning systems. Plain and narrow weave fabrics, including shuttle and rapier weaving, could help create three-dimensional structures for applications like vascular grafts. Cortland Biomedical designs, customizes, and manufactures high-performance biomedical textile structures with years of experience in medical textile engineering, including knitting, braiding, and weaving.
  • In March 2023, Riverpoint announced the expansion of biological offerings with the exclusive license of DSM biomedicals. Riverpoint Medical now has the exclusive licensed proprietary osteoconductive (OC) coating technology from DSM Biomedical. Osteoconduction is when bone grows on a surface and replaces it with new bone over time. The company made a product that can improve the environment for enhanced bone attachment. Osteoconductive coatings are used in orthopedic and dental implants and now in implantable textiles. This is a breakthrough in the orthopedic space where an osteoconductive scaffold is at the point of repair. The proprietary OC coating technology by Riverpoint Medical and DSM Biomedical improved implantable textiles for both surgeons and patients.
  • In October 2022, Cortland Biomedical announced textile structures incorporating radiopaque fibers. It can now process radiopaque fibers. By putting radiopaque fibers into diagnostic, it can allow devices to be visible under fluoroscopy, with their mechanical properties for the application. This will allow surgeons to position the device. Visibility can be seen through fluoroscopy months or years after surgical placement. The company's extensive range of knitting, weaving, and braiding capabilities enables it to make complex and customized textile structures with specific mechanical properties. Radiopaque fibers are currently available in PET and UHMWPE.

The biomedical textiles market is segmented and analyzed as follows:

By Fiber Type

  • Non-biodegradable Fiber
  • Biodegradable Fiber

By Fabric Type

  • Braided
  • Woven Materials
  • Non-Woven Materials
  • Others

By Application

  • Cardiovascular
  • Endovascular
  • Orthopedics
  • Neurovascular
  • Suture
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing cases of cardiovascular diseases
    • 4.1.2. Growing application in orthopedics
    • 4.1.3. Growing geriatric population
  • 4.2. Market Restraints
    • 4.2.1. Complexity in design and manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. BIOMEDICAL TEXTILES MARKET BY FIBER TYPE

  • 5.1. Introduction
  • 5.2. Non-biodegradable Fiber
  • 5.3. Biodegradable Fiber

6. BIOMEDICAL TEXTILES MARKET BY FABRIC TYPE

  • 6.1. Introduction
  • 6.2. Braided
  • 6.3. Woven Materials
  • 6.4. Non-Woven Materials
  • 6.5. Others

7. BIOMEDICAL TEXTILES MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Endovascular
  • 7.4. Orthopedics
  • 7.5. Neurovascular
  • 7.6. Suture
  • 7.7. Others

8. BIOMEDICAL TEXTILES MARKET BY GEOGRAPHY

  • 8.1. Global Overview
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Rest of South America
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Rest of Europe
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. United Arab Emirates
    • 8.5.3. Rest of Middle East and Africa
  • 8.6. Asia-Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Rest of Asia-Pacific

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Poly-Med Incorporated
  • 10.2. Medical Murray
  • 10.3. Bally Ribbon Mills
  • 10.4. Swicofil AG
  • 10.5. Royal DSM
  • 10.6. Confluent Medical Technologies
  • 10.7. 3M
  • 10.8. Atex Technologies
  • 10.9. Aran Biomedical Teoranta
  • 10.10. Freudenberg Group
  • 10.11. Trelleborg
  • 10.12. Asahi Kasei Corporation
  • 10.13. Elkem Silicones
  • 10.14. Cortland Biomedical